Global Veterinary Diagnostics Market to Reach USD 23.99 Billion by 2034 as AI, Point-of-Care Testing and Preventive Animal Healthcare Accelerate Growth

The Global Veterinary Diagnostics Market was valued at USD 9.72 Billion in 2025 and is projected to reach USD 23.99 Billion by 2034, expanding at a CAGR of 10.56% during 2026–2034. Growth is being supported by increasing pet ownership, greater expenditure on companion-animal healthcare, heightened awareness of zoonotic diseases, stricter livestock-health monitoring and continued adoption of rapid diagnostic technologies. Growing demand for point-of-care testing, molecular diagnostics, automated laboratory systems and artificial intelligence-enabled diagnostic platforms is also changing how veterinarians identify and manage diseases.

Market Growth Drivers and Emerging Opportunities

Veterinary diagnostics has become an important component of preventive animal healthcare because early and accurate disease detection helps veterinarians improve treatment decisions while supporting livestock productivity and disease-control programs. Rising incidence and surveillance of infectious and zoonotic diseases are encouraging governments, farms, laboratories and veterinary clinics to expand diagnostic capabilities.

Request a Free Sample Report for Comprehensive Market Insights:https://www.maximizemarketresearch.com/request-sample/34589/

A major opportunity is emerging in rapid point-of-care diagnostics, where testing can be performed directly in veterinary clinics or farm environments instead of requiring samples to be sent to centralized laboratories. Advances in AI-based image interpretation, automated hematology, digital cytology and molecular testing are shortening turnaround times and expanding the range of conditions that can be evaluated during a veterinary visit. The MMR analysis identifies point-of-care tools and AI-enabled diagnostic systems among the important opportunities shaping future market development.

United States Veterinary Diagnostics Market Trends and Investment in 2025

The United States remained a central market for veterinary diagnostic innovation during 2025. IDEXX introduced IDEXX Cancer Dx, a blood-based diagnostic panel designed initially for early detection of canine lymphoma, expanding the role of diagnostics from disease confirmation toward earlier screening. The company also launched the Catalyst Cortisol Test in June 2025, allowing veterinarians to obtain quantitative cortisol measurements at the point of care for dogs being evaluated for Addison’s disease and Cushing’s syndrome.

Investment in laboratory infrastructure also increased. In May 2025, Zoetis opened its largest diagnostics reference laboratory in Louisville, Kentucky, expanding testing capacity and using the location’s logistics infrastructure to improve sample movement and turnaround times across the United States.

Federal disease-surveillance infrastructure further supports diagnostic demand. USDA’s National Animal Health Laboratory Network reported USD 43.16 million in FY2025 allocated funding, including support for veterinary diagnostic infrastructure, high-pathogenic avian influenza testing and emerging dairy-cattle disease events.

Market Segmentation: Leading Segments

By testing type, Immunoassays or Immunodiagnostics dominated the Veterinary Diagnostics Market in 2025. Their leadership is supported by widespread use in detecting infectious diseases, hormones and metabolic conditions. ELISA, lateral-flow testing and automated immunoassay systems offer relatively rapid, sensitive and cost-effective testing options for both laboratories and point-of-care environments.

By end use, the Laboratories segment held approximately 49% of the market in 2025, representing the largest share. Diagnostic laboratories remain essential for disease surveillance, confirmatory testing, research, quality assurance and national programs for monitoring transboundary animal diseases.

Request a Free Sample Report for Comprehensive Market Insights:https://www.maximizemarketresearch.com/request-sample/34589/

Competitive Analysis

IDEXX Laboratories is identified by MMR as a leading participant in veterinary diagnostics. During 2025, the company expanded its diagnostic portfolio with IDEXX Cancer Dx and the Catalyst Cortisol Test, strengthening its position in preventive screening and in-clinic testing. IDEXX also reported continuing growth in diagnostic utilization and its installed instrument base.

Zoetis continued investing in both physical diagnostic infrastructure and artificial intelligence. Along with opening its Louisville reference laboratory, the company launched AI Masses for Vetscan Imagyst in June 2025. The capability uses deep-learning technology to evaluate common lymph-node and skin or subcutaneous lesions in clinics within minutes.

Heska Corporation, now part of Mars Petcare’s Science & Diagnostics ecosystem, strengthens Mars’ presence in point-of-care veterinary analyzers and integrated diagnostic technologies. Its combination with Antech’s reference laboratory and imaging capabilities creates a broader diagnostic offering spanning in-house instruments, laboratory testing and digital services.

Thermo Fisher Scientific remains an important participant in veterinary molecular and immunodiagnostic testing. Its veterinary diagnostic technologies support pathogen identification and infectious-disease surveillance, areas that are gaining importance as livestock producers and governments strengthen biosecurity systems. MMR identifies Thermo Fisher among the principal companies competing in this market.

Antech Diagnostics, part of Mars, accelerated technology development in 2025. In March, it launched trūRapid FOUR, an in-house lateral-flow test for canine vector-borne diseases. In May, the company introduced RapidRead Dental, an AI-enabled dental radiograph interpretation platform designed to provide tooth-by-tooth assessments in approximately ten minutes.

Regional Analysis

United States: The U.S. represents the principal contributor to North America, which led the global market in 2025. Advanced veterinary infrastructure, high companion-animal healthcare spending, major diagnostic companies and federal disease-surveillance programs sustain demand. USDA funding for NAHLN continues to expand laboratory readiness and diagnostic capacity.

United Kingdom: Growth is supported by strong veterinary services and government investment in disease surveillance. In May 2025, the UK government announced £10 million for advanced surveillance projects, including genomic sequencing for animal and plant pathogens.

Germany: Germany benefits from established veterinary research, livestock-health monitoring and institutions such as the Friedrich-Loeffler-Institut, which operates national reference capabilities for animal diseases. Continued surveillance of infections including West Nile virus supports demand for laboratory and molecular diagnostics.

France: France has a developed veterinary healthcare and animal-health industry, supported by diagnostic laboratories, disease-surveillance infrastructure and domestic companies including bioMérieux, Virbac and Alvedia listed in the MMR competitive landscape.

Japan: Japan maintains structured livestock disease-surveillance and diagnostic programs under the Ministry of Agriculture, Forestry and Fisheries. Government systems monitor infectious livestock diseases and support diagnostic testing through animal health facilities across the country.

China: China’s expanding pet-care economy and large livestock industry are creating demand for veterinary diagnostics. In July 2025, the Ministry of Agriculture and Rural Affairs strengthened requirements governing animal diagnostic institutions, including standardized licensing and digital veterinary-service administration, supporting greater formalization of the sector.

Request a Free Sample Report for Comprehensive Market Insights:https://www.maximizemarketresearch.com/request-sample/34589/

Key Players

Major companies profiled in the Global Veterinary Diagnostics Market include IDEXX Laboratories Inc., Zoetis Services LLC, Heska Corporation, Thermo Fisher Scientific Inc., Antech Diagnostics Inc., VCA Animal Hospitals, Neogen Corporation, bioMérieux SA, Virbac Corp., Alvedia, Randox Laboratories Ltd., Biopanda Reagents, INDICAL BIOSCIENCE GmbH, Fassisi GmbH, QIAGEN N.V., Agrolabo S.p.A., Shenzhen Mindray Bio-Medical Electronics, Shenzhen Bioeasy Biotechnology, BioNote Inc., FUJIFILM Holdings Corporation and IM3Vet Pty Ltd.

Conclusion

The Global Veterinary Diagnostics Market is moving toward faster, decentralized and increasingly intelligent testing systems. The strongest long-term opportunity is likely to come from combining point-of-care diagnostics with AI, molecular testing and connected laboratory platforms. Earlier disease detection, growing preventive pet healthcare, zoonotic-disease surveillance and livestock biosecurity requirements are expected to increase testing volumes throughout the forecast period. Companies able to deliver rapid results while integrating laboratory-grade accuracy, automation and digital clinical decision support are positioned to capture expanding demand through 2034.

View Our Latest Insights

Global Protein Drugs Market

Laboratory Centrifuge Market 

Biotechnology Market 

About Maximize Market Research

Maximize Market Research Pvt. Ltd. (MMR) is a global market research and consulting company that provides reliable, data-focused, and practical business insights. The firm serves a wide range of industries, including healthcare, pharmaceuticals, technology, automotive, electronics, chemicals, personal care, and consumer goods. Through market forecasts, competitive analysis, strategic consulting, and industry impact assessments, MMR helps organizations understand changing market conditions, identify growth opportunities, and make informed business decisions for long-term success.

Contact Us

MAXIMIZE MARKET RESEARCH PVT. LTD.
2nd Floor, Navale IT Park Phase 3
Pune Banglore Highway, Narhe
Pune, Maharashtra 411041, India
+91 9607365656
sales@maximizemarketresearch.com